Ikena Oncology Inc.

1.20
-0.05 (-4.00%)
At close: Apr 03, 2025, 3:59 PM
1.23
2.83%
After-hours: Apr 03, 2025, 07:55 PM EDT

Ikena Oncology Statistics

Share Statistics

Ikena Oncology has 40.26M shares outstanding. The number of shares has increased by -16.58% in one year.

Shares Outstanding 40.26M
Shares Change (YoY) -16.58%
Shares Change (QoQ) 0%
Owned by Institutions (%) 65.71%
Shares Floating 13.81M
Failed to Deliver (FTD) Shares 5.43K
FTD / Avg. Volume 4.31%

Short Selling Information

The latest short interest is 130.17K, so 0.32% of the outstanding shares have been sold short.

Short Interest 130.17K
Short % of Shares Out 0.32%
Short % of Float 0.68%
Short Ratio (days to cover) 0.28

Valuation Ratios

The PE ratio is -1.61 and the forward PE ratio is -1.76. Ikena Oncology's PEG ratio is 0.04.

PE Ratio -1.61
Forward PE -1.76
PS Ratio 0
Forward PS 2.7
PB Ratio 0.63
P/FCF Ratio -1.72
PEG Ratio 0.04
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Ikena Oncology.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 11.8, with a Debt / Equity ratio of 0.06.

Current Ratio 11.8
Quick Ratio 11.8
Debt / Equity 0.06
Debt / EBITDA -0.13
Debt / FCF -0.16
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-4.92M
Employee Count 10
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax -152K
Effective Tax Rate 0.31%

Stock Price Statistics

The stock price has increased by -6.72% in the last 52 weeks. The beta is 0.5, so Ikena Oncology's price volatility has been higher than the market average.

Beta 0.5
52-Week Price Change -6.72%
50-Day Moving Average 1.4
200-Day Moving Average 1.61
Relative Strength Index (RSI) 36.42
Average Volume (20 Days) 125.92K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -58.97M
Net Income -49.23M
EBITDA -58.97M
EBIT n/a
Earnings Per Share (EPS) -1.02
Full Income Statement

Balance Sheet

The company has 39.39M in cash and 7.52M in debt, giving a net cash position of 31.87M.

Cash & Cash Equivalents 39.39M
Total Debt 7.52M
Net Cash 31.87M
Retained Earnings -331.62M
Total Assets 141.51M
Working Capital 116.39M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -46M and capital expenditures 0, giving a free cash flow of -46M.

Operating Cash Flow -46M
Capital Expenditures 0
Free Cash Flow -46M
FCF Per Share -0.95
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

IKNA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for IKNA is $3, which is 140% higher than the current price. The consensus rating is "Hold".

Price Target $3
Price Target Difference 140%
Analyst Consensus Hold
Analyst Count 2
Stock Forecasts

Scores

Altman Z-Score -1.63
Piotroski F-Score 1